tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Silvan Tuerkcan, 221 are a BUY (96.09%), 9 are a HOLD (3.91%).
Analyst Silvan Tuerkcan, currently employed at JMP, carries an average stock price target met ratio of 43.24% that have a potential upside of 60.89% achieved within 127 days. Previously, Silvan Tuerkcan worked at OPPENHEIMER.
Silvan Tuerkcan’s has documented 430 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TSHA, Taysha Gene Therapies at 23-Jun-2026.
Analyst best performing recommendations are on PRME (PRIME MEDICINE, COMMON STOCK).
The best stock recommendation documented was for TERN (TERNS PHARMACEUTICALS) at 10/8/2025. The price target of $20 was fulfilled within 34 days with a profit of $11.74 (142.13%) receiving and performance score of 41.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Feb-2026
$53
$-2.37 (-4.28%)
$50
4 days ago
(23-Jul-2026)
7/8 (87.5%)
$-2.65 (-4.76%)
108
Hold Since 04-Feb-2026
$49
$-6.37 (-11.50%)
$45
13 days ago
(14-Jul-2026)
5/6 (83.33%)
$-6.77 (-12.14%)
203
Hold Since 29-Jul-2025
$46
$-9.37 (-16.92%)
$43
20 days ago
(07-Jul-2026)
6/7 (85.71%)
$-11.08 (-19.41%)
108
Hold Since 07-Jul-2026
$56
$0.63 (1.14%)
$54
20 days ago
(07-Jul-2026)
12/12 (100%)
$-1.08 (-1.89%)
118
Hold Since 19-Sep-2024
$52
$-3.37 (-6.09%)
$40
25 days ago
(02-Jul-2026)
5/7 (71.43%)
$-3.85 (-6.89%)
27
Which stock is Silvan Tuerkcan is most bullish on?
Which stock is Silvan Tuerkcan is most reserved on?
What Year was the first public recommendation made by Silvan Tuerkcan?
